RHI Magnesita (RHIM) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
FY 2023 revenue rose 8% to €3.572bn; adjusted EBITDA increased 9% to €543m and adjusted EBITA rose 7% to €409m.
Strong profitability and a €123m base-business working capital release supported €413m adjusted operating cash flow; acquisitions and pricing offset lower organic volumes.
Financial highlights
Gross profit increased 12% to €857m; gross margin rose 100bps to 24.0%, mainly on restored industrial pricing.
Adjusted profit after tax was €241m and adjusted EPS €4.98, up 2% YoY; adjusted finance charges increased to €92m from €66m.
Adjusted operating cash flow was €413m versus €155m in 2022; free cash flow was €258m versus €43m.
Revenue grew 10% in constant currency; acquisitions contributed 9% of revenue growth and €56m of EBITDA, above the ~€40m guidance.
Outlook and guidance
2024 base-business sales volumes are assumed flat YoY; the full-year effect of 2023 acquisitions is expected to add up to 10% to shipped volumes and €80m of EBITDA.
2024 adjusted EBITA guidance is ~€410m, with an adjusted EBITA margin of ~11.0%; pricing pressure is expected to partly offset M&A benefits.
2024 guidance includes capex of €170m, working capital intensity of ~24%, gearing of 2.0–2.5x and adjusted tax rate of 23–25%.
Depreciation guidance is ~€140m; adjusted finance charges are guided at ~€85m, including ~€50m net interest expense.
Latest events from RHI Magnesita
- Margin and profit growth offset revenue decline; guidance and deleveraging on track.RHIM
Q2 2026 - Margin expansion and sustainability driven by integration, innovation, and recycling.RHIM
Corporate presentation - EBITDA/EBITA up 15% year-over-year; guidance and strong cash generation reaffirmed.RHIM
Q1 2026 TU - Cost actions and M&A drove H2 recovery in 2025, supporting a cautious 2026 outlook.RHIM
Q4 2025 - Revenue and margins fell on weak demand and pricing, but H2 recovery is expected.RHIM
H1 2025 - Margins remain resilient despite weak demand and lower pricing, with EBITA guidance trimmed.RHIM
Q3 2024 TU - Stable revenue and strong cash flow; EBITA guidance reaffirmed despite weak demand.RHIM
H1 2024 - Weak Q1, overcapacity, and trade risks make H2 recovery vital for guidance.RHIM
Q1 2025 TU - Solid 2024 results and margin gains despite weak demand; modest growth seen for 2025.RHIM
H2 2024